CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

By laying the genetic risk signals over their new cell atlas, the team found the answers. They discovered that preeclampsia ...

EM, biochemical, and cell-based assays to examine how Gβγ interacts with and potentiates PLCβ3. The authors present evidence for multiple Gβγ interaction surfaces and argue that Gβγ primarily enhances ...

The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system ...

CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune responses. In cancer, however, this ...

Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...

AnaptysBio is splitting into a high-margin royalty company and a pipeline-focused biopharma, each with distinct valuation ...

Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...

Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics.

Researchers at the University of Geneva have built a molecular system that can tell the difference between a cancer cell and ...

Prize winner’s research reprograms tumor cells to trigger antitumor immunity   Cancer immunotherapies, such as checkpoint ...

The cells that line the inside of the gut may play a key role in triggering inflammation that drives MS, a study found.